• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.48% Nasdaq Up0.17%

    Synta Pharmaceuticals Corp. (SNTA)

    -NasdaqGM
    2.67 Down 0.13(4.64%) 10:48AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.7
    Mean Recommendation (last week):2.7
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:10.88
    Median Target:7.75
    High Target:27.00
    Low Target:1.00
    No. of Brokers:4

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Mar 12, 2014StifelDowngradeHoldSell
    Aug 30, 2012Stifel NicolausInitiated Hold
    Feb 28, 2011Canaccord GenuityUpgradeHoldBuy
    Nov 9, 2010MLV CapitalInitiated Buy
    Aug 26, 2010Morgan JosephInitiated Buy
    Feb 19, 2010RBC Capital MktsInitiated Sector Perform
    Feb 17, 2010Roth CapitalDowngradeBuyHold
    Nov 5, 2009Roth CapitalUpgradeHoldBuy
    Feb 27, 2009RBC Capital MktsDowngradeOutperformSector Perform
    Feb 27, 2009Rodman & RenshawDowngradeMkt OutperformMkt Perform

    More Upgrades & Downgrades for SNTA

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0111
    Buy0333
    Hold0000
    Underperform0111
    Sell0111

    Data provided by Thomson/First Call


    Currency in USD.